- Home
- BCV vs ME Comparison
BCV vs ME Comparison
Compare BCV & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCV
- ME
- Stock Information
- Founded
- BCV 1971
- ME 2006
- Country
- BCV United States
- ME United States
- Employees
- BCV N/A
- ME N/A
- Industry
- BCV Finance/Investors Services
- ME Precision Instruments
- Sector
- BCV Finance
- ME Health Care
- Exchange
- BCV Nasdaq
- ME Nasdaq
- Market Cap
- BCV 106.0M
- ME 113.9M
- IPO Year
- BCV N/A
- ME N/A
- Fundamental
- Price
- BCV $17.73
- ME $3.18
- Analyst Decision
- BCV
- ME Hold
- Analyst Count
- BCV 0
- ME 1
- Target Price
- BCV N/A
- ME $9.40
- AVG Volume (30 Days)
- BCV 26.3K
- ME 322.1K
- Earning Date
- BCV 01-01-0001
- ME 02-05-2025
- Dividend Yield
- BCV 8.13%
- ME N/A
- EPS Growth
- BCV N/A
- ME N/A
- EPS
- BCV N/A
- ME N/A
- Revenue
- BCV N/A
- ME $193,260,000.00
- Revenue This Year
- BCV N/A
- ME $21.93
- Revenue Next Year
- BCV N/A
- ME $17.31
- P/E Ratio
- BCV N/A
- ME N/A
- Revenue Growth
- BCV N/A
- ME N/A
- 52 Week Low
- BCV $14.09
- ME $2.66
- 52 Week High
- BCV $18.11
- ME $19.34
- Technical
- Relative Strength Index (RSI)
- BCV 39.38
- ME 38.04
- Support Level
- BCV $18.29
- ME $3.17
- Resistance Level
- BCV $18.38
- ME $3.50
- Average True Range (ATR)
- BCV 0.18
- ME 0.33
- MACD
- BCV -0.11
- ME 0.03
- Stochastic Oscillator
- BCV 0.00
- ME 6.67
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.